Preview

Regulatory Research and Medicine Evaluation

Advanced search

Microbiological examination of aerosols and sprays

https://doi.org/10.30895/1991-2919-2023-543

Abstract

Scientific relevance. Medicinal products formulated as aerosols and sprays are increasingly used in clinical practice, which makes the control of their quality, including microbiological testing, a highly topical issue. The current regulatory standards for microbiological testing of medicines provide little information on the quality control of metereddose aerosols. Proper microbiological sampling of these medicinal products can be difficult because of their primary packaging. The specialised analytical procedures set forth in international standards require verification and standardisation before use. Medicinal products in the form of sprays, despite being free from the disadvantages of aerosols, are more susceptible to the risk of microbial contamination.

Aim. The study aimed to describe specific aspects of sampling, to analyse the results of microbiological testing of aerosols and sprays, and to study the spectrum of microbial contaminants in these dosage forms.

Materials and methods. The authors retrospectively analysed the microbiological quality and sterility data for 181 batches of sprays, aerosols, and other inhalation dosage forms. The data were obtained at the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of Russia in 2020–2022. The Microbiology Laboratory tested the dosage forms according to the specifications provided by the manufacturers. The analysts used well-established testing procedures outlined in the current pharmacopoeias of the Russian Federation and the Eurasian Economic Union.

Results. The microbial counts exceeded the acceptable limits in 2.8% of the batches tested. The authors identified the microbial species that contaminated the medicinal products found to be non-compliant with regulatory requirements. Most of the non-compliant sprays that contained benzalkonium chloride as an antibacterial preservative were contaminated with Burkholderia cepacia complex species.

Conclusions. The authors consider it relevant to conduct research aiming at using the findings on potential contaminants to improve microbiological testing procedures for aerosols and sprays.

About the Authors

O. V. Gunar
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Olga V. Gunar, Dr. Sci. (Pharm.)

8/2 Petrovsky Blvd, Moscow 127051



N. G. Sakhno
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Nadezhda G. Sakhno, Cand. Sci. (Pharm.)

8/2 Petrovsky Blvd, Moscow 127051



References

1. Stein SW, Thiel CG. The history of therapeutic aerosols: a chronological review. J Aerosol Med Pulm Drug Deliv. 2017;30(1):20–41. https://doi.org/10.1089/jamp.2016.1297

2. Pobedin OA, Trukhacheva LA, Nechayeva EB. Quality assessment criteria for inhalation dosage forms. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2014;(2):20–5 (In Russ.). EDN: SIOVDF

3. Gobyzov OA, Ryabov MN, Yankova VG, Gribanova SV, Udyanskaya IL, Grigorieva VYu, Sazonova OP. Comparative analysis of Kameton spraying parameters of different manufacturers. Bulletin of Otorhinolaryngology. 2019;84(1):72–7 (In Russ.). EDN: MBGGIK

4. Sushinskaya OA, Golyak NS. Analysis of the range of medicines in the form of sprays in the Republic of Belarus. Innovations in medicine and pharmacy — 2016: materials of remote scientific-practical conference of students and young scientists. Minsk: BSMU; 2016. P. 814–8 (In Russ.).

5. Abdykadyrova MK, Zheterova SK. The development of modern pharmaceutical form—spray, antifungal action. Bulletin of KazNMU. 2015;(1):377–9 (In Russ.). EDN: ZVICFX

6. Chekman IS, Syrovaja AO, Andreeva SV, Makarov VA. Aerosols—dispersed systems. Kiev-Kharkiv: Digital Printing House No. 1; 2013 (In Russ.).

7. Kinev MYu, Petrov AYu. Сomparative analysis of the domestic and foreign pharmaceutical markets for the nose with the purpose of searching for future development prospects. Drug Development and Registration. 2018;(1):216–24 (In Russ.). EDN: YRTLFK

8. Tavares M, Kozak M, Balola A, Sá-Correia I. Burkholderia cepacia complex bacteria: a feared contamination risk in water-based pharmaceutical products. Clin Microbiol Rev. 2020;33(3):e00139-19. https://doi.org/10.1128/CMR.00139-19

9. Torbeck L, Raccasi D, Guilfoyle DE, Friedman RL, Hussong D. Burkholderia cepacia: this decision is overdue. PDA J Pharm Sci Technol. 2011;65(5):535–43. https://doi.org/10.5731/pdajpst.2011.00793

10. Ali M. Burkholderia cepacia in pharmaceutical industries. Int J Vaccines Vaccin. 2016;3(2):11–2. https://doi.org/10.15406/ijvv.2016.03.00064

11. Carson L, Favero MS, Bond WW, Peterson NJ. Morphological, biochemical, and growth characteristics of Pseudomonas cepacia from distilled water. Appl Microbiol. 1973;25(3):476–83. https://doi.org/10.1128/am.25.3.476-483.1973

12. Seelman SL, Bazaco MC, Wellman A, Hardy C, Fatica MK, Huang MJ, et al. Burkholderia cepacia complex outbreak linked to a no-rinse cleansing foam product, United States—2017–2018. Epidemiology and Infection. 2022;150:e154. https://doi.org/10.1017/S0950268822000668

13. Kolosova LV, Roshchina MV, Gunar OV. Drug contamination with the bacteria Burkholderia cepacia. Pharmacy. 2017;66(7):8–10 (In Russ.). EDN: ZQNWQH

14. Lord R, Jones AM, Horsley A. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Cochrane Database Syst Rev. 2020;4(4):CD009529. https://doi.org/10.1002/14651858.CD009529.pub4

15. Neznamova AV, Lopasteiskaya YaA, Molchanova EV , Ageeva NP , Viktorov DV. Identification of Burkholderia cepacia complex and Pseudomonas spp. using Vitek 2, an automated biochemical analyzer. Journal of VolgSMU, 2016;(3):109–12. EDN: WMIEBH

16. Kampf G. Adaptive microbial response to low-level benzalkonium chloride exposure. J Hosp Infect. 2018;100(3):e1–22. https://doi.org/10.1016/j.jhin.2018.05.019

17. Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004;130(1):131–41. https://doi.org/10.1016/j.otohns.2003.07.005

18. Luchinin DN, Molchanova EV, Zakharova IB, Viktorov DV. Assessment of resistance in Burkholderia pseudomallei to benzalkonium chloride and antibiotics. Problems of Particularly Dangerous Infections. 2022;(3):115–9 (In Russ.). https://doi.org/10.21055/0370-1069-2022-3-115-119

19. Ahn Y, Kim JM, Kweon O, Kim SJ, Jones RC, Woodling K, et al. Intrinsic resistance of Burkholderia cepacia complex to benzalkonium chloride. mBio. 2016;7(6):e01716-16. https://doi.org/10.1128/mBio.01716-16

20. Tavares M, Kozak M, Balola A, Coutinho CP, Godinho CP, Hassan AA, et al. Adaptation and survival of Burkholderia cepacia and B. contaminans during long-term incubation in saline solutions containing benzalkonium chloride. Front. Bioeng. Biotechnol. 2020;(8):630. https://doi.org/10.3389/fbioe.2020.00630

21. Johns BE, Purdy KJ, Tucker NP, Maddocks SE. Phenotypic and genotypic characteristics of small colony variants and their role in chronic infection. Microbiol Insights. 2015;8:15–23. https://doi.org/10.4137/MBI.S25800

22. Jimenez L. Microbial contamination control in the pharmaceutical industry. New York: Marcel Dekker; 2004.

23. Devanga Ragupathi NK, Veeraraghavan B. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update. Ann Clin Microbiol Antimicrob. 2019;18(1):7. https://doi.org/10.1186/s12941-019-0306-0


Supplementary files

Review

For citations:


Gunar O.V., Sakhno N.G. Microbiological examination of aerosols and sprays. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2023;13(3):464-473. (In Russ.) https://doi.org/10.30895/1991-2919-2023-543

Views: 865


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)